Search - tctmd.com

Displaying 121 - 140 of 491

Sort: Relevancy | Date

News Daily News

PCI of a Last Remaining Patent Vessel Is Rare and Risky, UK Data Confirm

Todd Neale

September 08, 2020

News Conference News ESC 2020

Acute MI Patients With Anemia May Require Fewer RBC Transfusions: REALITY

Caitlin E. Cox

September 01, 2020

News Daily News

CABG Loses Survival Advantage in Women at 10 Years: SYNTAXES

Yael L. Maxwell

August 20, 2020

News Daily News

Malnutrition Linked to Mortality, MACE in ACS Patients

Yael L. Maxwell

August 11, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina

Caitlin E. Cox

August 03, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Daily News

July 2020 News Roundup

L.A. McKeown

July 01, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

News Conference News CRT 2020

Operator Volume Matters in Left Main PCI: BCIS Analysis

Michael O'Riordan

March 05, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Conference News CRT 2020

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Michael O'Riordan

February 24, 2020

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Conference News AHA 2019

No Benefit of Colchicine in All-Comers PCI

Shelley Wood

November 17, 2019

Advertisement

PCI of a Last Remaining Patent Vessel Is Rare and Risky, UK Data Confirm

Acute MI Patients With Anemia May Require Fewer RBC Transfusions: REALITY

CABG Loses Survival Advantage in Women at 10 Years: SYNTAXES

Malnutrition Linked to Mortality, MACE in ACS Patients

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina

TCTMD’s Top 10 Most Popular Stories for July 2020

July 2020 News Roundup

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Operator Volume Matters in Left Main PCI: BCIS Analysis

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Outcome Differences Between Men and Women With PAD: EUCLID Insights

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

No Benefit of Colchicine in All-Comers PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content